Canadian Respiratory Journal (Jan 2009)

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)

  • Paul K Keith,
  • Caroline Koch,
  • Michel Djandji,
  • Jacques Bouchard,
  • Eliofotisti Psaradellis,
  • John S Sampalis,
  • R Robert Schellenberg,
  • R Andrew McIvor

DOI
https://doi.org/10.1155/2009/145071
Journal volume & issue
Vol. 16, no. Suppl A
pp. 17A – 24A

Abstract

Read online

OBJECTIVE: To evaluate the effectiveness of montelukast as add-on therapy for patients diagnosed with asthma and concurrent allergic rhinitis who remain uncontrolled while receiving inhaled corticosteroid (ICS) monotherapy or ICS/long-acting beta-2-agonist (LABA) therapy in a community practice setting.